IN2012DN02642A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02642A IN2012DN02642A IN2642DEN2012A IN2012DN02642A IN 2012DN02642 A IN2012DN02642 A IN 2012DN02642A IN 2642DEN2012 A IN2642DEN2012 A IN 2642DEN2012A IN 2012DN02642 A IN2012DN02642 A IN 2012DN02642A
- Authority
- IN
- India
- Prior art keywords
- cells
- oncogene
- differentiation stage
- present
- desired differentiation
- Prior art date
Links
- 230000004069 differentiation Effects 0.000 abstract 4
- 238000004519 manufacturing process Methods 0.000 abstract 3
- 108700020796 Oncogene Proteins 0.000 abstract 2
- 230000026969 oncogene-induced senescence Effects 0.000 abstract 2
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0641—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0644—Platelets; Megakaryocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/606—Transcription factors c-Myc
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009213645 | 2009-09-15 | ||
| PCT/JP2010/065903 WO2011034073A1 (ja) | 2009-09-15 | 2010-09-15 | 分化細胞の新規製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02642A true IN2012DN02642A (de) | 2015-09-11 |
Family
ID=43758674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2642DEN2012 IN2012DN02642A (de) | 2009-09-15 | 2010-09-15 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9200254B2 (de) |
| EP (2) | EP3159001B1 (de) |
| JP (4) | JP5791191B2 (de) |
| KR (2) | KR101667834B1 (de) |
| CN (2) | CN102712906B (de) |
| AU (1) | AU2010296415B2 (de) |
| BR (2) | BR122013008030B8 (de) |
| CA (1) | CA2774193C (de) |
| DK (2) | DK2500418T3 (de) |
| ES (2) | ES2725688T3 (de) |
| IN (1) | IN2012DN02642A (de) |
| RU (2) | RU2661107C1 (de) |
| WO (1) | WO2011034073A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10034900B2 (en) | 2010-09-30 | 2018-07-31 | National University Corporation Kumamoto University | Method of producing myeloid blood cells |
| DK2708597T3 (en) * | 2011-05-13 | 2018-02-05 | Univ Tokyo | POLYNUCLEAR MEGACARYOCYTIC CELL AND METHOD FOR PRODUCING BLADETS |
| RU2014117642A (ru) * | 2011-10-03 | 2015-11-10 | Ниссан Кемикал Индастриз, Лтд. | Способ получения мегакариоцитов и/или тромбоцитов из плюрипотентных стволовых клеток |
| GB201210857D0 (en) | 2012-06-19 | 2012-08-01 | Cambridge Entpr Ltd | Transcription factor mediated programming towards megakaryocytes |
| CN114558032B (zh) * | 2012-12-21 | 2025-07-29 | 安斯泰来再生医药协会 | 由多能干细胞制备血小板的方法及其组合物 |
| EP2955223B1 (de) * | 2013-02-08 | 2019-12-18 | Kyoto University | Herstellungsverfahren für megakaryozyten und blutplättchen |
| WO2014168255A1 (ja) * | 2013-04-12 | 2014-10-16 | 国立大学法人京都大学 | 巨核球の成熟化促進物質 |
| US20160060601A1 (en) | 2013-04-17 | 2016-03-03 | Nissan Chemical Industries, Ltd. | Medium composition and method for producing red blood cells using same |
| WO2014186508A1 (en) * | 2013-05-15 | 2014-11-20 | University Of Rechester | Human extensively self-renewing erythroblasts (esre) |
| US10112977B2 (en) | 2014-06-23 | 2018-10-30 | Toagosei Co., Ltd. | Peptide for inducing multinucleation in cells, and use therefor |
| EP3296393A4 (de) * | 2015-03-09 | 2018-10-03 | Megakaryon Corporation | Verfahren zur herstellung einer kultur mit megakaryozyten und verfahren zur herstellung von blutplättchen damit |
| BR112017022219A2 (pt) * | 2015-04-14 | 2018-07-31 | Univ Kyoto | método para produzir clone de célula-tronco adequado para induzir a diferenciação em células somáticas |
| KR20160129609A (ko) | 2015-04-30 | 2016-11-09 | 삼성전자주식회사 | Ｂｒａｆ 저해제를 포함하는 세포 또는 개체의 노화를 감소시키기 위한 조성물 및 그의 용도 |
| CA3003679A1 (en) * | 2015-11-02 | 2017-05-11 | Megakaryon Corporation | Method for producing platelets using reciprocating stirring device |
| JP7350246B2 (ja) | 2016-01-29 | 2023-09-26 | 国立大学法人京都大学 | 血小板産生促進剤のスクリーニング方法 |
| JP6879511B2 (ja) | 2016-01-29 | 2021-06-02 | 国立大学法人京都大学 | 血小板産生促進剤及びそれを用いた血小板の製造方法 |
| US11952587B2 (en) | 2017-03-06 | 2024-04-09 | Kyoto University | Method for producing platelets |
| FR3068366B1 (fr) * | 2017-06-30 | 2023-11-24 | Francais Du Sang Ets | Procede de production de progeniteurs erythroides |
| JP7153276B2 (ja) | 2017-07-07 | 2022-10-14 | 国立大学法人京都大学 | 血小板の製造方法および製造装置、ならびに血小板の製造装置における運転条件の決定方法 |
| WO2019059234A1 (ja) | 2017-09-19 | 2019-03-28 | 株式会社メガカリオン | 血小板の製造方法、血小板製剤の製造方法、および血液製剤の製造方法 |
| US11773374B2 (en) | 2017-09-19 | 2023-10-03 | Megakaryon Corporation | Method for producing purified platelets, method for producing platelet product, method for producing blood product, platelet preserving solution, platelet preserving agent, and method for preserving platelets |
| CN111836886A (zh) | 2018-01-05 | 2020-10-27 | 血小板生源说股份有限公司 | 用于产生巨核细胞的组合物和方法 |
| JP2021529770A (ja) | 2018-06-29 | 2021-11-04 | プレートレット バイオジェネシス， インコーポレイテッド | 薬物送達のための組成物およびその使用方法 |
| TW202045202A (zh) * | 2019-02-25 | 2020-12-16 | 國立陽明大學 | 用於治療肺纖維化和肺氣腫的組合物及其使用方法 |
| AU2020265737A1 (en) * | 2019-05-01 | 2021-12-02 | Immunebridge Inc. | Methods of making oligopotent and unipotent precursors |
| WO2021117886A1 (ja) | 2019-12-12 | 2021-06-17 | 国立大学法人千葉大学 | 巨核球および血小板を含む凍結乾燥製剤 |
| CN114829584B (zh) | 2019-12-13 | 2025-11-25 | 株式会社美加细胞 | 组合物和其用途 |
| WO2022092169A1 (ja) | 2020-10-27 | 2022-05-05 | 国立大学法人 長崎大学 | 骨形成組成物およびその用途 |
| JP7716851B2 (ja) * | 2020-12-28 | 2025-08-01 | イビデン株式会社 | 凍結保存液 |
| US20240352418A1 (en) | 2021-06-18 | 2024-10-24 | Megakaryon Corporation | Method for producing multinucleated megakaryocyte with enhanced platelet production capability, method for producing platelets, method for producing platelet preparation, and method for producing blood preparation |
| JPWO2023277153A1 (de) | 2021-06-30 | 2023-01-05 | ||
| WO2024010317A1 (ko) * | 2022-07-04 | 2024-01-11 | 주식회사 아트블러드 | 유전자 과발현 조합을 이용한 적혈구 분화능이 우수한 불멸화 적혈구전구세포주 확립, 이의 제조방법 및 용도 |
| JP2025534107A (ja) | 2022-10-18 | 2025-10-09 | ソングァン メディカル ファンデーション | 幹細胞から血小板前駆細胞への分化誘導用培地組成物及びそれを用いた分化方法 |
| JPWO2024143555A1 (de) | 2022-12-28 | 2024-07-04 | ||
| EP4692332A1 (de) | 2023-04-03 | 2026-02-11 | Otsuka Pharmaceutical Co., Ltd. | Herstellungsverfahren für megakaryozyten |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US572333A (en) | 1896-12-01 | Evaporating apparatus | ||
| CA2112492A1 (en) | 1991-06-28 | 1993-01-07 | Hava Avraham | A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| GB9502022D0 (en) * | 1995-02-02 | 1995-03-22 | Abuljadayel Ilham M S | A method for preparing lymphohaematopoietic progenitor cells |
| US5723333A (en) | 1995-02-10 | 1998-03-03 | Regents Of The University Of California | Human pancreatic cell lines: developments and uses |
| EP0808364B1 (de) | 1995-02-10 | 2005-11-30 | The Regents of the University of California | Menschliche pancreas zellinien: entwicklungen und anwendungen |
| US20050159378A1 (en) * | 2001-05-18 | 2005-07-21 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA) |
| RU2346039C2 (ru) * | 2002-09-27 | 2009-02-10 | БайоИ, Инк. | Композиция (варианты), способ и набор для разделения клеток |
| JP3896482B2 (ja) * | 2002-10-07 | 2007-03-22 | 独立行政法人産業技術総合研究所 | 分化細胞の作製方法 |
| JP2004350601A (ja) | 2003-05-29 | 2004-12-16 | Tanabe Seiyaku Co Ltd | 霊長類動物の胚性幹細胞から造血系細胞への分化方法 |
| JP4706208B2 (ja) | 2004-08-27 | 2011-06-22 | 株式会社アイル | 造血幹細胞の製造方法 |
| JP2006141356A (ja) | 2004-11-24 | 2006-06-08 | Institute Of Physical & Chemical Research | Ｅｓ細胞から樹立された造血幹細胞 |
| WO2007047583A2 (en) * | 2005-10-18 | 2007-04-26 | National Jewish Medical And Research Center | Conditionally immortalized long-term stem cells and methods of making and using such cells |
| US20090220465A1 (en) * | 2005-11-07 | 2009-09-03 | The General Hospital Corporation | Methods and compositions for modulation of stem cell aging |
| ZA200804673B (en) * | 2005-12-13 | 2009-11-25 | Univ Kyoto | Nuclear reprogramming factor |
| US8058064B2 (en) | 2006-10-04 | 2011-11-15 | The University Of Tokyo | Sac-like structure enclosing hematopoietic progenitor cells produced from ES cells and method for preparing blood cells |
| CN101617043B (zh) * | 2007-10-31 | 2014-03-12 | 国立大学法人京都大学 | 核重编程方法 |
| CN101492676B (zh) * | 2008-09-16 | 2011-02-16 | 中国科学院广州生物医药与健康研究院 | 用脑膜细胞生成诱导的多能性干细胞的方法及其用途 |
-
2010
- 2010-09-15 CA CA2774193A patent/CA2774193C/en active Active
- 2010-09-15 US US13/496,321 patent/US9200254B2/en active Active
- 2010-09-15 EP EP16202612.4A patent/EP3159001B1/de active Active
- 2010-09-15 KR KR1020127009225A patent/KR101667834B1/ko active Active
- 2010-09-15 CN CN201080042161.7A patent/CN102712906B/zh active Active
- 2010-09-15 RU RU2016139042A patent/RU2661107C1/ru active
- 2010-09-15 DK DK10817186.9T patent/DK2500418T3/en active
- 2010-09-15 BR BR122013008030A patent/BR122013008030B8/pt active IP Right Grant
- 2010-09-15 IN IN2642DEN2012 patent/IN2012DN02642A/en unknown
- 2010-09-15 RU RU2012114427/10A patent/RU2603094C2/ru active
- 2010-09-15 KR KR1020167027550A patent/KR101834687B1/ko active Active
- 2010-09-15 ES ES16202612T patent/ES2725688T3/es active Active
- 2010-09-15 CN CN201510530896.9A patent/CN105385659B/zh not_active Expired - Fee Related
- 2010-09-15 WO PCT/JP2010/065903 patent/WO2011034073A1/ja not_active Ceased
- 2010-09-15 ES ES10817186.9T patent/ES2664194T3/es active Active
- 2010-09-15 EP EP10817186.9A patent/EP2500418B1/de active Active
- 2010-09-15 JP JP2011531940A patent/JP5791191B2/ja active Active
- 2010-09-15 DK DK16202612.4T patent/DK3159001T3/da active
- 2010-09-15 AU AU2010296415A patent/AU2010296415B2/en active Active
- 2010-09-15 BR BR112012005710A patent/BR112012005710B1/pt active IP Right Grant
-
2015
- 2015-02-13 JP JP2015026547A patent/JP2015130866A/ja active Pending
- 2015-08-03 JP JP2015153048A patent/JP6265437B2/ja active Active
- 2015-10-28 US US14/925,508 patent/US10087419B2/en active Active
-
2016
- 2016-11-29 JP JP2016231020A patent/JP6382917B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02642A (de) | ||
| PH12013500554A1 (en) | Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation | |
| PH12013500760B1 (en) | Microorganism producing o-phosphoserine and method of producing l-cysteine or derivatives thereof from o-phosphoserine using the same | |
| MY163339A (en) | A method of producing ingenol-3-angelate | |
| MX360499B (es) | Cepas microbianas, composiciones y metodos para incrementar el fosfato disponible para las plantas. | |
| EP2671964A4 (de) | Hochfestes kaltgewalztes stahlblech mit hervorragender bearbeitbarkeit und hohem streckgrenzenverhältnis sowie herstellungsverfahren dafür | |
| EA201270280A1 (ru) | Соединения пиримидина в качестве ингибиторов при лечении туберкулеза | |
| IN2012KN02804A (de) | ||
| IN2012DN06442A (de) | ||
| MX2011008621A (es) | Proceso para la purificacion de lipopeptidos. | |
| IN2012DN01342A (de) | ||
| AU2014230812A8 (en) | Process for making benzoxazepin compounds | |
| MY158910A (en) | Surface modified silicic acid semi-gels | |
| UA106988C2 (uk) | Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та необхідні проміжні сполуки магнію | |
| PH12012501153A1 (en) | Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds | |
| MX2011013790A (es) | Derivados de flavina. | |
| MX339772B (es) | Metodo y composicion para producir azucar clarificada. | |
| IN2012DN01929A (de) | ||
| WO2010059916A3 (en) | Preparation of docetaxel | |
| IN2012DN03032A (de) | ||
| MX2012003888A (es) | Semigeles de acido silicico de superficie modificada. | |
| WO2013072766A3 (en) | Process for cabazitaxel and intermediates thereof | |
| GB2514285A (en) | Intermediates for a novel process of preparing imatinib and related tyrosine kinase inhibitors | |
| MX2011012460A (es) | Proceso para la preparacion de olmesartan medoxomil. | |
| MX2013000219A (es) | Preparacion de tesetaxel y compuestos relacionados e intermediario de sintesis correspondiente. |